Improving adherence to and persistence with oral therapy of osteoporosis.

Details

Serval ID
serval:BIB_F5A0E952DC32
Type
Article: article from journal or magazin.
Collection
Publications
Title
Improving adherence to and persistence with oral therapy of osteoporosis.
Journal
Osteoporosis international
Author(s)
Bianchi M.L., Duca P., Vai S., Guglielmi G., Viti R., Battista C., Scillitani A., Muscarella S., Luisetto G., Camozzi V., Nuti R., Caffarelli C., Gonnelli S., Albanese C., De Tullio V., Isaia G., D'Amelio P., Broggi F., Croci M.
ISSN
1433-2965 (Electronic)
ISSN-L
0937-941X
Publication state
Published
Issued date
05/2015
Peer-reviewed
Oui
Volume
26
Number
5
Pages
1629-1638
Language
english
Notes
Publication types: Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
Osteoporosis treatment has low adherence and persistence. This study evaluated if greater patient involvement could improve them. At 12 months, only 114 out of 344 participants were "fully adherent and persistent" (all drug doses taken throughout the study). Only frequency of drug administration had a significant influence on adherence.
Osteoporosis affects millions of individuals worldwide. There are now several effective drugs, but adherence to and persistence with treatment are low. This 12-month multicenter, prospective, randomized study evaluated the efficacy of two different methods aimed at improving adherence and persistence through greater patient involvement, compared with standard clinical practice.
Three hundred thirty-four post-menopausal women, receiving an oral prescription for osteoporosis for the first time, were recruited and randomized into three groups: group 1 (controls, managed according to standard clinical practice) and groups 2 and 3 (managed with greater patient and caregiver involvement and special reinforcements: group 2, instructed to use several different "reminders"; group 3, same "reminders" as group 2, plus regular phone calls from and meetings at the referring Center). All enrolled women had two visits (baseline and 12 months).
Of 334 enrolled women, 247 (74%) started the prescribed therapy. Of those who started, 219 (88.7%) persisted in therapy for at least 10 months. At final evaluation, only 114 women were considered as "fully adherent and persistent" (all doses taken throughout the 12 months). There were no significant differences regarding "full adherence" among the three randomized groups. The frequency of drug administration had a significant influence: weekly administration had a >5-fold higher adherence and monthly administration an 8-fold higher adherence (p < 0.0001) than daily administration.
The special effort of devising and providing additional reminders did not prove effective. Additional interventions during the follow-up, including costly interventions such as phone calls and educational meetings, did not provide significant advantages.
Keywords
Administration, Oral, Aged, Aged, 80 and over, Bone Density Conservation Agents/administration & dosage, Bone Density Conservation Agents/therapeutic use, Drug Administration Schedule, Female, Humans, Italy, Medication Adherence/psychology, Medication Adherence/statistics & numerical data, Middle Aged, Osteoporosis, Postmenopausal/drug therapy, Osteoporosis, Postmenopausal/psychology, Patient Education as Topic/methods, Patient Participation, Prospective Studies, Telephone
Pubmed
Web of science
Create date
14/01/2020 7:57
Last modification date
15/01/2020 6:26
Usage data